Academic Journal
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease
العنوان: | A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease |
---|---|
المؤلفون: | Faridar, Alireza, Eid, Abdulmunaim M., Thome, Aaron D., Zhao, Weihua, Beers, David R., Pascual, Maria B., Nakawah, Mohammad O., Roman, Gustavo C., Davis, Charles S., Grundman, Michael, Masdeu, Joseph C., Appel, Stanley H. |
المساهمون: | Alzheimer's Association |
المصدر: | Translational Neurodegeneration ; volume 12, issue 1 ; ISSN 2047-9158 |
بيانات النشر: | Springer Science and Business Media LLC |
سنة النشر: | 2023 |
الوصف: | Trial registration ClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered, https://classic.clinicaltrials.gov/ct2/show/NCT05821153 |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1186/s40035-023-00387-5 |
DOI: | 10.1186/s40035-023-00387-5.pdf |
DOI: | 10.1186/s40035-023-00387-5/fulltext.html |
الاتاحة: | http://dx.doi.org/10.1186/s40035-023-00387-5 https://link.springer.com/content/pdf/10.1186/s40035-023-00387-5.pdf https://link.springer.com/article/10.1186/s40035-023-00387-5/fulltext.html |
Rights: | https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0 |
رقم الانضمام: | edsbas.E96A5902 |
قاعدة البيانات: | BASE |
DOI: | 10.1186/s40035-023-00387-5 |
---|